Bispecific Antibodies: A Frontier in Advanced Cancer Treatments
In the ever-evolving realm of cancer therapy, immunotherapy has emerged as a groundbreaking approach, offering renewed hope where traditional treatments often fall short. Among the innovations driving this transformation, monoclonal antibodies (mAbs) have stood out for their ability to target specific molecules with remarkable precision. However, despite their effectiveness, monoclonal antibodies often face limitations in … Read more
